Article
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
2020-03-26
Abstract excerpt
<h4>BACKGROUND</h4> A significant gap in pancreatic ductal adenocarcinoma (PDAC) patient’s care is the lack of molecular parameters characterizing tumors and allowing a personalized treatment. The goal of this study was to examine whole PDAC transcriptomic profiles to define a signature that would predict aggressiveness and treatment responsiveness better than done until now. <h4>METHODS AND PATIENTS</h4> Tumors...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 018d2725-a2fe-5c3e-b2a6-970bb988d24b
- DOI
- 10.1101/2020.03.25.998138
